Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorRuijin Hospital
About this trial
Clinical observational studies using epidemiologic theories and methods. Through the collection of various clinically relevant data, specific outcomes are evaluated in hematologic transplant patients, providing high quality real-world data for clinical practice, informing public health decision-making, and reducing the burden of disease
Eligibility criteria
Qualifiers
At least one visit to a stem cell transplant center beginning January 1, 2021
Proposed to undergo or have undergone hematopoietic stem cell transplantation
Disqualifiers
Long-term follow-up information for patients not available for any reason (e.g., unavailable or with serious concomitant disease) according to investigator opinion
Due to alcohol and drug addiction thus affecting their ability to follow the requirements of the study
Presence of conditions that could jeopardize patient safety or affect their adherence to the protocol, according to the investigator's opinion
Trial design
Treatments tested in this trial
- Not listed
Trial groups
3,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov